Abstract
The clinical relevance of T cells in the control of a diverse set of human cancers is now beyond doubt. However, the nature of the antigens that allow the immune system to distinguish cancer cells from noncancer cells has long remained obscure. Recent technological innovations have made it possible to dissect the immune response to patient-specific neoantigens that arise as a consequence of tumor-specific mutations, and emerging data suggest that recognition of such neoantigens is a major factor in the activity of clinical immunotherapies. These observations indicate that neoantigen load may form a biomarker in cancer immunotherapy and provide an incentive for the development of novel therapeutic approaches that selectively enhance T cell reactivity against this class of antigens.
Keywords
ImmunotherapyImmune systemCancer immunotherapyAntigenImmunologyCancerBiologyBiomarkerCancer researchMedicineGenetics
Affiliated Institutions
Related Publications
The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer
Definitive experimental evidence from mouse cancer models and strong correlative clinical data gave rise to the Cancer Immunoediting concept that explains the dual host-protecti...
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
Abstract Immune checkpoint inhibitors have shown significant therapeutic responses against tumors containing increased mutation-associated neoantigen load. We have examined the ...
Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
Abstract A core challenge in cancer immunotherapy is to understand the basis for efficacious vaccine responses in human patients. In previous work we identified a melanoma patie...
Cancer immunotherapy
The remarkable specificity of the immune system through antigen recognition has long attracted investigators to the possibility of immune‐based therapy for cancer. Previous canc...
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
The immune system influences the fate of developing cancers by not only functioning as a tumour promoter that facilitates cellular transformation, promotes tumour growth and scu...
Publication Info
- Year
- 2015
- Type
- review
- Volume
- 348
- Issue
- 6230
- Pages
- 69-74
- Citations
- 4573
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
4573
OpenAlex
Cite This
Ton N. Schumacher,
Robert D. Schreiber
(2015).
Neoantigens in cancer immunotherapy.
Science
, 348
(6230)
, 69-74.
https://doi.org/10.1126/science.aaa4971
Identifiers
- DOI
- 10.1126/science.aaa4971